Previously, using an orthotopic Lewis lung carcinoma (LLC) model, we showed that reprogrammed CD8+ T-cells (rCD8+ T-cells) isolated from the bone marrow and spleen have antitumor potential [11, 12]. This evidence concerns the gene CD8A and Carcinoma, Lewis Lung.